Nuvo Pharmaceuticals Inc trades with the ticker NRI on the TSX and is in the Drug Manufacturers – Specialty & Generic industry.
Overview
Nuvo Pharmaceuticals Inc., a healthcare company, provides prescription and non-prescription products for pain, allergy, and dermatology in the United States, Canada, Europe, and internationally. The company operates through three segments: Commercial Business, Production and Service Business, and Licensing and Royalty Business. It offers Blexten, an antihistamine drug for the symptomatic relief of allergic rhinitis and chronic spontaneous urticarial; Cambia, a nonsteroidal anti-inflammatory drug for the treatment of migraine; Resultz, a non-prescription product intended to kill head lice and remove their eggs from hair; and Suvexx/Treximet, a medicine for migraine. The company also provides Pennsaid, a topical pain product that is used to treat the signs and symptoms of osteoarthritis of the knee; Pennsaid 2%, a follow-on product to Pennsaid; Vimovo for relief of the signs and symptoms of osteoarthritis, rheumatoid arthritis, and ankylosing spondylitis; Yosprala for secondary prevention of cardiovascular and cerebrovascular events; and Heated Lidocaine/Tetracaine (HLT) Patch, a topical patch applied prior to painful medical procedures, such as venous access, blood draws, needle injections and minor dermatologic surgical procedures. The company was formerly known as Nuvo Research Inc. and changed its name to Nuvo Pharmaceuticals Inc. in March 2016. Nuvo Pharmaceuticals Inc. was founded in 1983 and is headquartered in Mississauga, Canada.
Looking to invest in Nuvo Pharmaceuticals Inc? Our analysis brings in the key facts, competitor research and valuation metrics for you to make an informed decision.
Table of Contents
show
NRI.TO Stock Price and Key Stats
ETF Key Stats
Exchange: TSX
Market Cap : $10.363MM
PE Ratio: 2.6
Price: 44.8 (Updated: 3/12/2024 0:47:16)
Nuvo Pharmaceuticals Inc (NRI) vs Competitors in Drug Manufacturers – Specialty & Generic
Lets see how NRI.TO stacks up against others in the Drug Manufacturers – Specialty & Generic asset management industry. We have identified its main peers as:Aleafia Health Inc, Aphria Inc, Acerus Pharmaceuticals Corporation, Correvio Pharma Corp, The Supreme Cannabis Company, Inc
.Drug Manufacturers – Specialty & Generic Industry Comparisons
| Company | Market Cap ($MM) | P/E Ratio | EV/EBITDA | Dividend Yield |
|---|---|---|---|---|
| Aleafia Health Inc (ALEF) | $189.563 | N/A | 0.0 | 0.0% |
| Aphria Inc (APHA) | $4,439.753 | N/A | 598.009 | 0.0% |
| Acerus Pharmaceuticals Corporation (ASP) | $2.775 | N/A | -2.796 | 0.0% |
| Correvio Pharma Corp (CORV) | $37.067 | N/A | 0.0 | 0.0% |
| The Supreme Cannabis Company, Inc (FIRE) | $255.583 | N/A | 0.0 | 0.0% |
EV/EBITDA: Enterprise Value to Earnings Before Interest, Taxes, Depreciation, and Amortization – this ratio compares the value of a company, including debt, to the company’s cash earnings less non-cash expenses
Industry: companies that have a lot in common
Market Cap: Market Capitalization – the total value of all a corporation’s stock
N/A: Not Applicable or Not Available
P/E: Price-to-Earnings – this ratio relates a corporation’s share price to its earnings per share
Price: Stock Price – current value to buyers and sellers
Dividend Yield: Dividend or Distribution Yield
Comparisons within Drug Manufacturers – Specialty & Generic
- Nuvo Pharmaceuticals Inc (NRI) vs Aleafia Health Inc (ALEF)
- NRI has higher EPS (0.024 vs -0.274). ALEF has higher dividend yield (0.0% vs 0.0%). ALEF has a P/E under 0, indicating NRI (P/E 2.6) is in a better position.
- Nuvo Pharmaceuticals Inc (NRI) vs Aphria Inc (APHA)
- APHA has higher EPS (0.116 vs 0.024). APHA has higher dividend yield (0.0% vs 0.0%). APHA has a P/E under 0, indicating NRI (P/E 2.6) is in a better position.
- Nuvo Pharmaceuticals Inc (NRI) vs Acerus Pharmaceuticals Corporation (ASP)
- NRI has higher EPS (0.024 vs -4.41). ASP has higher dividend yield (0.0% vs 0.0%). ASP has a P/E under 0, indicating NRI (P/E 2.6) is in a better position.
- Nuvo Pharmaceuticals Inc (NRI) vs Correvio Pharma Corp (CORV)
- NRI has higher EPS (0.024 vs -0.879). CORV has higher dividend yield (0.0% vs 0.0%). CORV has a P/E under 0, indicating NRI (P/E 2.6) is in a better position.
- Nuvo Pharmaceuticals Inc (NRI) vs The Supreme Cannabis Company, Inc (FIRE)
- NRI has higher EPS (0.024 vs -0.052). FIRE has higher dividend yield (0.0% vs 0.0%). FIRE has a P/E under 0, indicating NRI (P/E 2.6) is in a better position.
Our Recommendation: Hold
Shows positive EPS growth from this year to next, suggesting improving profitability.
How to Buy NRI stock on the TSX
You can buy on pretty much any online brokerage in Canada, since it trades on the TSX. If you are looking for some easy options take a look at these two:| Image | Product Title | Features | Price |
|---|---|---|---|
Editor's Choice  |
| Get $25 Signup Bonus | |
Reliable Pick  |
| Get $50 Free Stock Trades |
